...
首页> 外文期刊>Toxicology in vitro: an international journal published in association with BIBRA >Mebendazole, an antiparasitic drug, inhibits drug transporters expression in preclinical model of gastric peritoneal carcinomatosis
【24h】

Mebendazole, an antiparasitic drug, inhibits drug transporters expression in preclinical model of gastric peritoneal carcinomatosis

机译:梅白唑,一种抗披物药物,抑制胃腹膜癌癌临床前模型中的药物转运蛋白表达

获取原文
获取原文并翻译 | 示例

摘要

The present study aimed to investigate whether MBZ down-regulates "drug transporter expression (ABCB1, ABCC1, SLC47A1). mRNA expression level of ABCB1, ABCC1 and SLC47A1 was evaluated by qPCR and protein expression levels MDR-1 was performed by western blotting in malignant ascites cells (AGP-01) treated with MBZ for 24 h. The mRNA expression level of ABCB1 and ABCC1 significantly decreased at a 1.0 mu M of MBZ compared to negative control, while SLC47A1 extremely decreased at all tested concentrations of MBZ. Protein expression levels MDR-1 significantly decreased at a 1.0 mu M of MBZ compared to negative control. Therefore, our results showed MBZ may play an important role in inhibiting MDR gene expression in malignant ascites cells.
机译:本研究旨在研究MBZ下调“药物转运蛋白表达(ABCB1,ABCC1,SLC47A1)。通过QPCR和蛋白质表达水平评估ABCB1,ABCC1和SLC47A1的mRNA表达水平MDR-1通过Western印迹在恶性肿瘤中进行 用MBz处理的腹水细胞(AGP-01)24小时。与阴性对照相比,ABCB1和ABCC1的mRNA表达水平在1.0μm的MBz中显着降低,而SLC47A1在所有测试的MBZ浓度下极大地降低。蛋白表达水平 与阴性对照相比,MDR-1的MDR-1在1.0 mu m的1.0 mu m中显着降低。因此,我们的结果表明MBZ可能在抑制恶性腹水细胞中抑制MDR基因表达中的重要作用。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号